Skip to main content
Fig. 6 | BMC Pediatrics

Fig. 6

From: Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts

Fig. 6

Additively prognostic effects of E2F3 with MYCN amplification or age of diagnosis in neuroblastoma. a Pediatric neuroblastoma patients were divided into four sub-groups based on the expression levels of E2F3 and MYCN amplification. Different overall survival in each sub-group of pediatric neuroblastoma patients was determined using the Kaplan–Meier survival analysis in TARGET, GSE16476, GSE85047 and E-MTAB-1781 datasets. b Pediatric neuroblastoma patients were divided into four sub-groups based on the expression levels of E2F3 and age of diagnosis. Different overall survival in each sub-group of pediatric neuroblastoma was determined

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us